RISEDRONATE

risedronate sodium 35 mg enteric tablet, 4
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Corticosteroid-induced osteoporosis

Restriction

Indication: Osteoporosis

Restriction

Indication: Established osteoporosis
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 4 # of repeats: 5 DPMQ: $34.21 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Actonel EC